🏅 FDA Orphan Designation
Zycubo
copper histidinate
Manufacturer: Sentynl Therapeutics, Inc.
Indicated for:
FDA-Approved Indications (1)
Marburg hemorrhagic feverOrphan Designation
treatment of Menkes disease in pediatric patients
Indications & Usage
1 INDICATIONS AND USAGE ZYCUBO is indicated for the treatment of Menkes disease in pediatric patients. ZYCUBO is a copper replacement product indicated for the treatment of Menkes disease in pediatric patients. ( 1 ) Limitations of Use ZYCUBO is not indicated for the treatment of Occipital Horn Syndrome. ( 1 ) Limitations of Use ZYCUBO is not indicated for the treatment of Occipital Horn Syndrome.
💙 Support Programs
View all →Zycubo
Eton Pharmaceuticals
Where shown, WAC (Wholesale Acquisition Cost) is an estimate only — your actual cost depends on your insurance plan. Always verify pricing with your pharmacy or insurer.
Medical disclaimer: This information is for educational purposes only. Always consult a qualified healthcare provider before making treatment decisions. Data sourced from FDA and current as of our last update.